IBDEI1DG ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24307,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24307,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,24307,1,2,0)
 ;;=2^MYELODYSPLASTIC SYNDROME,UNSPEC
 ;;^UTILITY(U,$J,358.3,24307,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,24308,0)
 ;;=157.9^^136^1487^47
 ;;^UTILITY(U,$J,358.3,24308,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24308,1,1,0)
 ;;=1^157.9
 ;;^UTILITY(U,$J,358.3,24308,1,2,0)
 ;;=2^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,24308,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,24309,0)
 ;;=187.9^^136^1487^48
 ;;^UTILITY(U,$J,358.3,24309,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24309,1,1,0)
 ;;=1^187.9
 ;;^UTILITY(U,$J,358.3,24309,1,2,0)
 ;;=2^PENILE CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24309,2)
 ;;=^267252
 ;;^UTILITY(U,$J,358.3,24310,0)
 ;;=163.9^^136^1487^50
 ;;^UTILITY(U,$J,358.3,24310,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24310,1,1,0)
 ;;=1^163.9
 ;;^UTILITY(U,$J,358.3,24310,1,2,0)
 ;;=2^PLEURAL CANCER
 ;;^UTILITY(U,$J,358.3,24310,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,24311,0)
 ;;=185.^^136^1487^51
 ;;^UTILITY(U,$J,358.3,24311,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24311,1,1,0)
 ;;=1^185.
 ;;^UTILITY(U,$J,358.3,24311,1,2,0)
 ;;=2^PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,24311,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,24312,0)
 ;;=287.9^^136^1487^52
 ;;^UTILITY(U,$J,358.3,24312,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24312,1,1,0)
 ;;=1^287.9
 ;;^UTILITY(U,$J,358.3,24312,1,2,0)
 ;;=2^PURPURA/OTH HEMORRHAGIC COND
 ;;^UTILITY(U,$J,358.3,24312,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,24313,0)
 ;;=189.9^^136^1487^65
 ;;^UTILITY(U,$J,358.3,24313,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24313,1,1,0)
 ;;=1^189.9
 ;;^UTILITY(U,$J,358.3,24313,1,2,0)
 ;;=2^URINARY ORGAN CANCER,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,24313,2)
 ;;=^267269
 ;;^UTILITY(U,$J,358.3,24314,0)
 ;;=142.9^^136^1487^55
 ;;^UTILITY(U,$J,358.3,24314,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24314,1,1,0)
 ;;=1^142.9
 ;;^UTILITY(U,$J,358.3,24314,1,2,0)
 ;;=2^SALIVARY GLAND CANCER
 ;;^UTILITY(U,$J,358.3,24314,2)
 ;;=^267009
 ;;^UTILITY(U,$J,358.3,24315,0)
 ;;=160.9^^136^1487^1
 ;;^UTILITY(U,$J,358.3,24315,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24315,1,1,0)
 ;;=1^160.9
 ;;^UTILITY(U,$J,358.3,24315,1,2,0)
 ;;=2^ACCESSORY SINUS CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24315,2)
 ;;=^267127
 ;;^UTILITY(U,$J,358.3,24316,0)
 ;;=151.9^^136^1487^60
 ;;^UTILITY(U,$J,358.3,24316,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24316,1,1,0)
 ;;=1^151.9
 ;;^UTILITY(U,$J,358.3,24316,1,2,0)
 ;;=2^STOMACH CANCER
 ;;^UTILITY(U,$J,358.3,24316,2)
 ;;=^73532
 ;;^UTILITY(U,$J,358.3,24317,0)
 ;;=186.9^^136^1487^61
 ;;^UTILITY(U,$J,358.3,24317,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24317,1,1,0)
 ;;=1^186.9
 ;;^UTILITY(U,$J,358.3,24317,1,2,0)
 ;;=2^TESTICULAR CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24317,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,24318,0)
 ;;=164.9^^136^1487^43
 ;;^UTILITY(U,$J,358.3,24318,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24318,1,1,0)
 ;;=1^164.9
 ;;^UTILITY(U,$J,358.3,24318,1,2,0)
 ;;=2^MEDIATINUM CANCER,PART UNSPEC
 ;;^UTILITY(U,$J,358.3,24318,2)
 ;;=^267150
 ;;^UTILITY(U,$J,358.3,24319,0)
 ;;=141.9^^136^1487^64
 ;;^UTILITY(U,$J,358.3,24319,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24319,1,1,0)
 ;;=1^141.9
 ;;^UTILITY(U,$J,358.3,24319,1,2,0)
 ;;=2^TONGUE CANCER
 ;;^UTILITY(U,$J,358.3,24319,2)
 ;;=^266995
 ;;^UTILITY(U,$J,358.3,24320,0)
 ;;=239.9^^136^1487^46
 ;;^UTILITY(U,$J,358.3,24320,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24320,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,24320,1,2,0)
 ;;=2^NEOPLASM,UNSPEC NATURE,UNSPEC SITE
 ;;
 ;;$END ROU IBDEI1DG
